Skip to main content
All lobbying filings

NATIONAL KIDNEY FOUNDATION

Lobbying for NATIONAL KIDNEY FOUNDATION

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $50,000.00 expenses · posted Oct 18, 2025

Official filing document

 Bills named in this filing 11
  • HR 628
    Honor Our Living Donors Act
  • S 957
    Honor Our Living Donors Act
  • S 1552
    Living Donor Protection Act of 2025
  • HR 4583
    Living Donor Protection Act of 2025
  • HR 4582
    To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
  • HR 1518
    New Era of Preventing End-Stage Kidney Disease Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 1973
    Treat and Reduce Obesity Act of 2025
  • HR 4231
    Treat and Reduce Obesity Act of 2025
  • S 1261
    CONNECT for Health Act of 2025
  • HR 4206
    CONNECT for Health Act of 2025
 Lobbying activity 3
Health Issues

Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).

Medicare/Medicaid

Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.

Budget/Appropriations

FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 Appropriations for Indian Health Service.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem